We are live on ! Find out more
DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale Portfolio holdings

AUM $59.2B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+8.43%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$34.3B
AUM Growth
+$4.15B
Cap. Flow
+$1.92B
Cap. Flow %
5.6%
Top 10 Hldgs %
23.44%
Holding
1,439
New
97
Increased
478
Reduced
443
Closed
54

Top Buys

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$200M
2
AMZN icon
Amazon
AMZN
+$126M
3
DB icon
Deutsche Bank
DB
+$109M
4
ISRG icon
Intuitive Surgical
ISRG
+$92.2M
5
WFC icon
Wells Fargo
WFC
+$83.3M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$126M
2
ABT icon
Abbott
ABT
+$79.1M
3
VFC icon
VF Corp
VFC
+$49M
4
JPM icon
JPMorgan Chase
JPM
+$48.5M
5
BNTX icon
BioNTech
BNTX
+$46.9M

Sector Composition

Rank Sector Weight
1 Technology 25.97%
2 Healthcare 15.46%
3 Financials 11.88%
4 Communication Services 9.65%
5 Consumer Discretionary 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMP icon
1151
Standard Motor Products
SMP
$885M
$291K ﹤0.01%
6,784
STOK icon
1152
Stoke Therapeutics
STOK
$2.08B
$291K ﹤0.01%
8,900
IQ icon
1153
iQIYI
IQ
$1.31B
$288K ﹤0.01%
18,443
+886
+5% +$13.2K
EGRX
1154
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$288K ﹤0.01%
6,900
MRCY icon
1155
Mercury Systems
MRCY
$6.52B
$284K ﹤0.01%
4,311
-20,704
-83% -$1.43M
KROS icon
1156
Keros Therapeutics
KROS
$212M
$282K ﹤0.01%
6,650
RDUS
1157
DELISTED
Radius Health, Inc.
RDUS
$281K ﹤0.01%
15,200
ARCT icon
1158
Arcturus Therapeutics
ARCT
$200M
$280K ﹤0.01%
8,100
ZION icon
1159
Zions Bancorporation
ZION
$10.3B
$280K ﹤0.01%
5,342
MNKD icon
1160
MannKind Corp
MNKD
$1.26B
$279K ﹤0.01%
55,000
BHP icon
1161
BHP
BHP
$230B
$276K ﹤0.01%
4,282
MRSN
1162
DELISTED
Mersana Therapeutics
MRSN
$274K ﹤0.01%
840
EPZM
1163
DELISTED
Epizyme, Inc
EPZM
$274K ﹤0.01%
32,300
CWT icon
1164
California Water Service
CWT
$3.06B
$272K ﹤0.01%
5,000
BLD
1165
DELISTED
TopBuild
BLD
$270K ﹤0.01%
1,389
+121
+10% +$25.1K
PCVX icon
1166
Vaxcyte
PCVX
$8.67B
$269K ﹤0.01%
12,000
BEPC icon
1167
Brookfield Renewable
BEPC
$6.17B
$268K ﹤0.01%
6,316
-23,894
-79% -$1.02M
QTTB icon
1168
Q32 Bio
QTTB
$466M
$267K ﹤0.01%
2,139
ANNX icon
1169
Annexon
ANNX
$883M
$265K ﹤0.01%
12,000
TMX
1170
DELISTED
Terminix Global Holdings, Inc.
TMX
$264K ﹤0.01%
5,626
+5,126
+1,025% +$252K
GGG icon
1171
Graco
GGG
$13.5B
$260K ﹤0.01%
3,485
RAPT
1172
DELISTED
RAPT Therapeutics
RAPT
$260K ﹤0.01%
1,000
SPCE icon
1173
Virgin Galactic
SPCE
$415M
$259K ﹤0.01%
+281
New +$160K
COIN icon
1174
Coinbase
COIN
$39.2B
$256K ﹤0.01%
+1,020
New +$265K
PING
1175
DELISTED
Ping Identity Holding Corp.
PING
$256K ﹤0.01%
11,000

Similar funds

DekaBank Deutsche Girozentrale's Q2 2021 Portfolio in Review

As of Q2 2021, DekaBank Deutsche Girozentrale held 1,439 positions worth $34.3B, up 14% from $30.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

DekaBank Deutsche Girozentrale deployed $1.92B of net new capital in Q2 2021, opening 97 new positions and adding to 478 existing holdings. Its largest new stake was Stellantis: 10,647,151 shares worth $207M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Broadcom, an estimated $126M trimmed.

  • DekaBank Deutsche Girozentrale's largest Q2 2021 buy was Stellantis: 10,647,151 shares worth $207M.
  • DekaBank Deutsche Girozentrale added most to Amazon in Q2 2021, an estimated $126M increase.
  • DekaBank Deutsche Girozentrale's biggest Q2 2021 reduction was Broadcom, cutting an estimated $126M.
  • DekaBank Deutsche Girozentrale fully exited CureVac in Q2 2021, selling an estimated $6.93M.
  • DekaBank Deutsche Girozentrale's ten largest holdings make up 23% of its $34.3B portfolio in Q2 2021.
  • DekaBank Deutsche Girozentrale opened 97 new positions and closed 54 in Q2 2021.
  • DekaBank Deutsche Girozentrale's portfolio value rose 14% quarter-over-quarter to $34.3B.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2021, filed 5 Aug 2021.